First Week of February 2026 Options Trading For Cytokinetics (CYTK)

Investors considering Cytokinetics Inc (CYTK) may find attractive opportunities in options trading, with the $30 put offering a potential 12.67% return (18.87% annualized) if it expires worthless, given a 69% probability based on current data. Conversely, selling a covered call at the $35 strike could yield a 24.35% return if the stock is called away, or a 16.89% boost (25.15% annualized) if the contract expires worthless, with a 42% chance of that outcome; implied volatilities for the put and call are 76% and 68% respectively, compared to a trailing twelve month volatility of 47%.

Analysis

The analysis for Cytokinetics Inc. (CYTK), currently trading at $32.57 per share, highlights two specific option strategies for the February 2026 expiration, offering potentially attractive risk-reward profiles. Selling the $30.00 strike put contract, with a current bid of $3.80, allows an investor to collect a premium that would reduce the effective share purchase price to $26.20 if assigned. This strike is approximately 8% out-of-the-money, and current data suggests a 69% probability of this put expiring worthless, in which case the seller would realize a 12.67% return on the cash commitment, or an 18.87% annualized YieldBoost. Alternatively, selling the $35.00 strike covered call, with a bid of $5.50, could generate a total return of 24.35% if CYTK shares are called away at $35.00. Should this call, which is approximately 7% out-of-the-money, expire worthless (a 42% estimated probability), the collected premium would represent a 16.89% boost to returns, or a 25.15% annualized YieldBoost. Significantly, the implied volatilities for these options are elevated at 76% for the put and 68% for the call, substantially exceeding CYTK's actual trailing twelve-month volatility of 47%. This discrepancy indicates that option premiums are relatively rich, benefiting sellers, but also signals heightened market expectations for future price movements or specific catalysts related to the company.

Key Decisions for Investors

• Investors interested in acquiring CYTK shares at a lower effective cost basis could consider selling the February 2026 $30.00 strike cash-secured puts, which targets an effective entry price of $26.20 or offers an 18.87% annualized return on cash if the option expires unexercised.
• Current CYTK shareholders aiming to generate income while willing to cap upside potential above $35.00 might evaluate selling the February 2026 $35.00 strike covered calls, potentially achieving a 24.35% total return if shares are called away or a 25.15% annualized premium yield if the option expires worthless.
• Given the notable premium of implied volatility (68-76%) over historical volatility (47%), investors should recognize that while these option selling strategies offer attractive yields, this also reflects increased market anticipation of share price volatility for CYTK, warranting careful risk assessment.